Life is never the same after you hear those three little words, “You’ve got cancer.”
Suddenly you find yourself in the fight of your life and EVERYTHING changes.
Life becomes a whirlwind of doctors’ appointments and harsh treatments that make you feel so sick you can begin to wonder if the side effects are worse than the cancer.
But you’re willing to do whatever it takes to defeat this killer, so you keep fighting and trudge on.
And make no mistake about it, Big Pharma knows exactly how desperate that fight can become, and it’s not above exploiting it for profit.
Case in point, Afinitor a new–as yet unproven–cancer drug that no doubt has its maker seeing dollar signs.
But if you or a loved one are battling cancer it may be time to finally draw that “do not cross” line in the sand. Because it turns out this supposedly “life-saving” treatment could actually end up shortening yours.
Let me explain…
Zero evidence Afinitor extends lives
In 2009 the FDA gave the thumbs up to Afinitor despite the fact that there was zero evidence that it can actually extend the lives of desperate cancer patients.
Let that sink in for a moment, a heavy duty cancer drug that may not add a single day to cancer patient’s lives—but that comes with some potentially crippling side effects (more on those in a moment—was allowed on the market.
And if you’re wondering why, join the club. But I can tell you HOW.
As absurd as it sounds the drug was given the green light based on extrapolated data from fast, small and cheap clinical trials. These so-called “surrogate measures” allow drugs to get rushed to the market ahead of any actual data on health outcomes.
And the madness doesn’t end there. Since it got that first thumbs up Afinitor has been put before the FDA five MORE times to be approved for new uses and each time the drug has gotten the agency’s rubber stamp.
Sales have catapulted to an astounding estimated 1.6 billion this year. (Not surprising since a single pill will set you back around $450!)
2,700 deaths linked to the drug so far
Another number has been rising right along with those sales, however, and that’s the number of serious adverse reactions which are hovering around 9,000 as of right now, and a terrifying 2,700 of those are deaths.
But we shouldn’t really be surprised since the research we do have on this drug made it clear what we were getting into.
One in five users developed a potentially deadly lung condition. And in a trial on breast cancer 63 percent of users had to have their dosage cut or stop treatment altogether. In fact, 30 percent of those in the trials ended up with a laundry list of troubling side effects.
Unproven, sickening and even deadly potential side effects, and an astronomical price tag make saying no to Afinitor an easy choice.
Latest posts by Dr. Glenn Rothfeld (see all)
- Q&A: Can vitamin C really kill cancer cells? - October 1, 2016
- Q&A: Have they really removed the mercury in vaccines? - September 11, 2016
- Dangerous vitamin deficiency can lead to misdiagnosis - August 20, 2016